The latest news in renal cancer
By analysing tumours from patients treated with immunotherapy for advanced kidney cancer in three clinical…
The Food and Drug Administration (FDA) granted accelerated approval to the combination of nivolumab and…
Chemotherapy halves the risk of a rare form of kidney cancer coming back after surgery,…
An experimental drug already shown to be safe and help some patients with clear cell…
Updated results have been released from the Phase 3 CheckMate -214 study evaluating the combination…
Scientists at the Max Delbrück Center for Molecular Medicine in Berlin, Germany, (MDC) have discovered…
Scientists report promising activity of a novel drug that targets a key molecular driver of…
The likelihood of a patient responding to immune checkpoint blockade may depend on B cells…
The researchers used the most advanced genomic and proteomic technologies available to tease out their…
A new study indicates that kidney damage is fairly common in patients who take immunotherapy…